The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

Published:2018-06 Issue: Volume:200 Page:83-89
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Wiviott Stephen D.,Raz Itamar,Bonaca Marc P,Mosenzon Ofri,Kato Eri T,Cahn Avivit,Silverman Michael G,Bansilal Sameer,Bhatt Deepak L,Leiter Lawrence A.,McGuire Darren K.,Wilding John PH,Gause-Nilsson Ingrid AM,Langkilde Anna Maria,Johansson Peter A.,Sabatine Marc S.

Funder

Duke Clinical Research Institute

School of Medicine

Bristol-Myers Squibb

Forest Laboratories

Boston Scientific

St. Jude Medical

Hebrew University

Johnson and Johnson

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Heart disease and stroke statistics—2011 update: a report from the American Heart Association;Roger;Circulation,2011

2. American Association of Clinical Endocrinologists and American College of Endocrinology—clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015;Handelsman;Endocr Pract,2015

3. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials;Udell;Lancet Diabetes Endocrinol,2015

4. Alogliptin after acute coronary syndrome in patients with type 2 diabetes;White;N Engl J Med,2013

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction;International Journal of Molecular Sciences;2024-08-13

2. Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study;BMC Cardiovascular Disorders;2024-08-02

3. Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?;Archiv der Pharmazie;2024-07-29

4. Safety and efficacy of dapagliflozin in patients with type 2 diabetes mellitus during fasting in the month of Ramadan: an experience from tertiary care hospital;International Journal of Diabetes in Developing Countries;2024-07-29

5. Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project);JMIR Research Protocols;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3